From Name:
From Email:
To Name:
To Email:

Optional Message:

New indication granted for Repatha for wider group of patients: Adults with CVD

from Pharmacy Practice News

The FDA granted a new indication for evolocumab (Repatha, Amgen) as the first PCSK9 inhibitor to prevent heart attacks, strokes and coronary revascularizations in adults with established cardiovascular disease (CVD). more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063